The Department of Veterans Affairs is launching a clinical trial to study a hallucinogen-based treatment for veterans with PTSD and alcohol use disorder. The research could inform future VA mental health and addiction treatment options, but it is not an immediate change to benefits or coverage.
Read full story at Stars and Stripes →Related Topics
va-healthcareptsdsubstance-use-disorderclinical-trialspsychedelic-assisted-therapy